Revenue: The sum of all revenue fields included for a company's operating activities.
Tvardi Therapeutics, Inc. (TVRD) Revenue data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-6.80M |
|
-- |
|
-- |
|
$7.05M |
|
$-7.05M |
|
$0.25M |
|
$-6.80M |
|
$-6.80M |
|
$-6.80M |
|
$-6.80M |
|
$-6.80M |
|
$-6.80M |
|
$-7.05M |
|
$-7.03M |
|
9.38M |
|
9.38M |
|
$-0.73 |
|
$-0.73 |
|
| Balance Sheet Financials | |
$25.33M |
|
$0.04M |
|
$0.49M |
|
$25.82M |
|
$11.26M |
|
-- |
|
$0.05M |
|
$11.31M |
|
$14.51M |
|
$14.20M |
|
$14.51M |
|
9.38M |
|
| Cash Flow Statement Financials | |
$-5.86M |
|
$4.98M |
|
-- |
|
$20.73M |
|
$19.85M |
|
$-0.88M |
|
$0.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.86M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.91% |
|
-47.92% |
|
-26.35% |
|
-46.91% |
|
$1.55 |
|
$-0.62 |
|
$-0.62 |
|